arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up

Jupiter Neurosciences, Inc.

JUNS Health Care Biotechnology: Pharmaceutical Preparations
$2.58
▼ -7.9% Today
as of Oct 22, 16:49 ET
Last 30 days -24.34% Sep 14 → Oct 22
$2.34 $2.63 $2.92 $3.20 $3.49 Sep 14 Sep 22 Sep 29 Oct 07 Oct 14 Oct 22
Open
$2.76
High
$2.76
Low
$2.55
Volume
$10,087
Avg Vol
$276,560
Mkt Cap
$3M
P/E (TTM)
—
Beta
—
52w High
$135.75
52w Low
$2.25
Div Yield
—
Shares Out
$664,670

Recent Press Releases & News last 60 days · 2 items

JUNS earnings at a glance

Over its last 2 reports the stock rose the next day 1 time and fell 1, moving ±2.8% on average; after the most recent report on May 14, 2026 it moved +4.2%. JUNS beat the consensus EPS estimate in 1 of its last 3 reported quarters. The share price of $2.58 sits near its 52-week low.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$2.25
$136
0% of range
Avg surprise (last 3)
-18.1%
Avg reaction (last 2)
+1.3%
50% positive

Earnings trends

EPS — actual vs estimate Actual Estimate
$-4.08$-3.06$-2.04$-1.01$0.01 Actual $-0.07Actual $-0.02Actual $0.01Actual $-0.02Actual $-0.05Est $-0.03Actual $-0.07Est $-0.07Actual $-0.07Est $-0.08Actual $-0.06Actual $-4.08 SepMarJunSepMar/2025Jun/2025Sep/2025Mar/2026Jun
Revenue vs Net Income Revenue Net income
$-2M$-2M$-1M$-552,916$25,457 Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $-4.08 — — — — financials
Thu May 14, 2026Mar/2026 $-0.06 — — -20.0% +4.2% earnings
Fri Nov 14, 2025Sep/2025 $-0.07 $-0.08 +12.5% — — earnings
Mon Aug 18, 2025Jun/2025 $-0.07 $-0.07 0.0% — — earnings
Thu May 15, 2025Mar/2025 $-0.05 $-0.03 -66.7% — -1.5% earnings
Mon Sep 30, 2024Sep 2024 $-0.02 — — — — financials
Sun Jun 30, 2024Jun 2024 $0.01 — — — — financials
Sun Mar 31, 2024Mar 2024 $-0.02 — — — — financials
Sat Sep 30, 2023Sep 2023 $-0.07 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$24,245$18,652———$0——
Cost of revenue$3,181$4,362——————
Gross profit$21,064$14,290——————
Operating income$-3M$-2M—$-2M$-2M$-2M—$-493,547
Net income$-2M$-2M—$-2M$-2M$-2M—$-591,021
EPS (diluted)$-4.08$-0.06—$-0.07$-5.09$-0.05—$-0.02

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$2M$2M$4M$723,797$2M$3M$4M$253
Inventory$135,290$148,068$159,790—————
Total current assets$3M$3M$5M$2M$3M$4M$5M$514
Total assets$4M$4M$6M$3M$4M$5M$6M$85,546
Long-term debt————————
Total liabilities$4M$7M$7M$3M$3M$2M$2M$6M
Total equity$-365,966$-3M$-2M$57,417$1M$3M$4M$-6M

Implied volatility — last 90 days

No IV snapshots yet for JUNS.

IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.

Sector peers

JUNS earnings FAQ

How does JUNS stock usually react to earnings?

Across the last 2 reports the average next-day move was ±2.8%, up 1 times and down 1 times.

🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.